Jean-Louis Montastruc (François Montastruc)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 54

Top Topics

Clostridium Difficile

Arterial Hypertension

Top Venues

Fundamental & clinical pharmacology

British journal of clinical pharmacology

European journal of clinical pharmacology

Movement disorders : official journal of the Movement Disorder Society

This page only lists publications with an associated author ORCID identifier.

Publications

Jean-Louis Montastruc
Thirst and drugs: A study in the World Health Organization's pharmacovigilance database. British journal of clinical pharmacology (2024)
Jean-Louis Montastruc, Alessandra Bura Rivière
Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study. British journal of clinical pharmacology (2024)
Jean-Louis Montastruc
Peptic ulcers with ChEIs, NSAIDs. Journal of the American Geriatrics Society (2024)
Jean-Louis Montastruc, Alessandra Bura Rivière
Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study. British journal of clinical pharmacology 90 (6) (2024)
Jean-Louis Montastruc
Thirst and drugs: A study in the World Health Organization's pharmacovigilance database. British journal of clinical pharmacology 90 (6) (2024)
Jean-Louis Montastruc
Safety of pitolisant: a study in the WHO international pharmacovigilance database. European journal of clinical pharmacology (2023)
Jean-Louis Montastruc
Safety of pitolisant: a study in the WHO international pharmacovigilance database. European journal of clinical pharmacology 79 (4) (2023)
Jean-Louis Montastruc, Samuel Tessier, Alessandra Bura-Riviere
Differences in the location of bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: A study in the World Health Organization's pharmacovigilance database. British journal of clinical pharmacology (2023)
Jean-Louis Montastruc, Alessandra Bura Rivière
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study. European journal of clinical pharmacology 80 (2) (2023)
Jean-Louis Montastruc, Alessandra Bura Rivière
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study. European journal of clinical pharmacology (2023)
Jean-Louis Montastruc, François Montastruc, Alessandra Bura Rivière
Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study. European journal of clinical pharmacology (2023)
Jean-Louis Montastruc
Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins. British journal of clinical pharmacology (2023)
Jean-Louis Montastruc, Samuel Tessier, Alessandra Bura-Riviere
Differences in the location of bleeding with direct oral anticoagulants vs. vitamin K antagonists: A study in the World Health Organization's pharmacovigilance database. British journal of clinical pharmacology (2023)
Jean-Louis Montastruc
Drugs and bruxism: a study in the World Health Organization's pharmacovigilance database. British journal of clinical pharmacology (2023)
Jean-Louis Montastruc, Alessandra Bura Rivière
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study. European journal of clinical pharmacology 80 (2) (2023)
Jean-Louis Montastruc, Pierre Biron, Agnès Sommet
NVX-Cov2373 Novavax Covid-19 vaccine: A further analysis of its efficacy using multiple modes of expression. Fundamental & clinical pharmacology 36 (6) (2022)
Jean-Louis Montastruc, Geneviève Durrieu
Drug-induced hypohidrosis and anhidrosis: analysis of the WHO pharmacovigilance database 2000-2020. European journal of clinical pharmacology 78 (5) (2022)
Jean-Louis Montastruc
Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010-2019. British journal of clinical pharmacology (2022)
Claire De Canecaude, Vanessa Rousseau, Agnès Sommet, Jean-Louis Montastruc
Tramadol-induced hypoglycemia: A pharmacovigilance study. Fundamental & clinical pharmacology 35 (5) (2021)
Julia Guion-Firmin, Samuel Tessier, Marion Lepelley, Jean-Luc Faillie, Jean-Louis Montastruc
Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study. Fundamental & clinical pharmacology (2021)
Jean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, Geneviève Durrieu, Agnès Sommet, François Montastruc, Haleh Bagheri
Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. British journal of clinical pharmacology 87 (11) (2021)
Beatrice Bouhanick, François Montastruc, Samuel Tessier, Clara Brusq, Vanina Bongard, Jean-Michel Senard, Jean-Louis Montastruc, Fabrice Herin
Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal. European journal of clinical pharmacology 77 (12) (2021)
Jean-Louis Montastruc, Julia Guion-Firmin, Claire de Canecaude, Adeline Ruyssens-Witrand, Genevieve Durrieu, Margaux Lafaurie, Agnès Sommet
Drugs and Dupuytren's disease: a pharmacovigilance study in VigiBase®. European journal of clinical pharmacology 77 (10) (2021)
Jean-Louis Montastruc, Pierre Biron, Agnès Sommet
Efficacy of COVID-19 vaccines: Several modes of expression should be presented in scientific publications. Fundamental & clinical pharmacology (2021)
Julia Guion-Firmin, Samuel Tessier, Jean-Louis Montastruc
Diarrhea and angiotensin II receptor blockers: Is there any difference between the different drugs? Fundamental & clinical pharmacology (2021)
Alain Braillon, Susan Bewley, Aubrey Blumsohn, Florian Naudet, Jean-Louis Montastruc, Joel R Lexchin
Antidepressants are not safe during pregnancy and in women of child-bearing age. British journal of clinical pharmacology 88 (5) (2021)
Jean-Louis Montastruc, Vanessa Rousseau, Geneviève Durrieu, Haleh Bagheri
Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®. European journal of clinical pharmacology 76 (10) (2020)
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A Ferran, Pierre-Louis Toutain
Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? Clinical pharmacokinetics 58 (7) (2020)
Claire Bourrel, Alice Zacarin, Vanessa Rousseau, Jean-Louis Montastruc, Haleh Bagheri
Are potentially inappropriate and anticholinergic medications being prescribed for institutionalized elderly subjects? Fundamental & clinical pharmacology 34 (6) (2020)
Jean-Louis Montastruc, Geneviève Durrieu
Amiodarone and Parkinsonism: a pharmacovigilance study. Fundamental & clinical pharmacology 35 (4) (2020)
Cécile Conte, Vanessa Rousseau, Charlotte Vert, François Montastruc, Jean-Louis Montastruc, Geneviève Durrieu, Pascale Olivier
Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Fundamental & clinical pharmacology 34 (4) (2020)
Tatiana Pacheco, François Montastruc, Vanessa Rousseau, Leila Chebane, Maryse Lapeyre-Mestre, Christel Renoux, Jean-Louis Montastruc
Reply to: Comment on "Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiological study". Movement disorders : official journal of the Movement Disorder Society 35 (2) (2020)
Constance Bordet, Vanessa Rousseau, François Montastruc, Jean-Louis Montastruc
QT prolongation and vortioxetine: a post-marketing study and comparison with other serotonin reuptake inhibitors. Psychopharmacology 237 (4) (2020)
Jean-Louis Montastruc, Vanessa Rousseau, Claire de Canecaude, Anne Roussin, François Montastruc
Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study. European journal of clinical pharmacology 76 (9) (2020)
Claire de Canecaude, Vanessa Rousseau, Leila Chebane, Margaux Lafaurie, Geneviève Durrieu, Jean-Louis Montastruc
Can tramadol really induce hyponatraemia? A pharmacovigilance study. British journal of clinical pharmacology 87 (2) (2020)
Jean-Louis Montastruc, Pierre-Louis Toutain
A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. Drug safety 43 (7) (2020)
Charlotte Fouque, Romain Martin, Florent Seguro, Jean-Louis Montastruc, Claire de Canecaude
Splenic Infarction in a Narcoleptic Patient Treated With Methylphenidate, Venlafaxine, and Pitolisant. The Annals of pharmacotherapy 54 (2) (2019)
Fabien Despas, Vanessa Rousseau, Margaux Lafaurie, Claire De Canecaude, Geneviève Durrieu, Haleh Bagheri, François Montastruc, Jean-Louis Montastruc
Are lipid-lowering drugs associated with a risk of cataract? A pharmacovigilance study. Fundamental & clinical pharmacology 33 (6) (2019)
Pierre Sabatier, Jacques Amar, François Montastruc, Vanessa Rousseau, Leila Chebane, Béatrice Bouhanick, Jean-Louis Montastruc
Breast cancer and spironolactone: an observational postmarketing study. European journal of clinical pharmacology 75 (11) (2019)
Sibylle de Germay, Manuela Rueter, François Montastruc, Vanessa Rousseau, Maryse Lapeyre Mestre, Jean-Louis Montastruc
Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database. Fundamental & clinical pharmacology 33 (4) (2019)
Tatiana Pacheco, François Montastruc, Vanessa Rousseau, Leila Chebane, Maryse Lapeyre-Mestre, Christel Renoux, Jean-Louis Montastruc
Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study. Movement disorders : official journal of the Movement Disorder Society 35 (1) (2019)
Mélanie Araujo, Caroline Hurault-Delarue, Claire Bouilhac, Dominique Petiot, Justine Benevent, Christophe Vayssière, Sabine Vidal, Jean-Louis Montastruc, Christine Damase-Michel, Isabelle Lacroix
Non-steroidal anti-inflammatory drug prescriptions from the 6th month of pregnancy: impact of advice from health authorities. Fundamental & clinical pharmacology 33 (5) (2019)
Jean-Louis Montastruc, Justine Benevent, Vanessa Rousseau, Leila Chebane, Emmanuelle Bondon-Guitton, Geneviève Durrieu, Jean-Louis Montastruc, Agnès Sommet
Statins and diabetes: is there any difference between the different statins? Pharmacoepidemiology and drug safety 26 (10) (2019)
Julien Mahé, Emilie Patras de Campaigno, Anne-Laure Chené, Jean-Louis Montastruc, Fabien Despas, Pascale Jolliet
Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase. British journal of clinical pharmacology 84 (10) (2018)
Geneviève Durrieu, Quentin Dardonville, Michel Clanet, Jean-Louis Montastruc
Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab. Fundamental & clinical pharmacology 33 (1) (2018)
François Montastruc, Justine Benevent, Vanessa Rousseau, Geneviève Durrieu, Agnès Sommet, Jean-Louis Montastruc
Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase®. Fundamental & clinical pharmacology 33 (1) (2018)
François Montastruc, Farzin Khosrow-Khavar, Agnès Sommet, Christel Renoux, Jean-Louis Montastruc
Tamoxifen administration and the risk of Parkinsonism. European journal of clinical pharmacology 75 (1) (2018)
Chloé Danet, Mélanie Araujo, Marie-Andrée Bos-Thompson, Ghyslaine Portolan, Sophie Gautier, Laurence Vanlemmens, Sophie Bonenfant, Annie-Pierre Jonville-Béra, Judith Cottin, Thierry Vial, Françoise Bavoux, Jean-Louis Montastruc, Christine Damase-Michel, Justine Benevent, Isabelle Bourgeois-Mondon, Isabelle Lacroix
Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiology and drug safety 27 (12) (2018)
Justine Benevent, Caroline Hurault-Delarue, Mélanie Araujo, François Montastruc, Jean-Louis Montastruc, Isabelle Lacroix, Christine Damase-Michel
Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties. Fundamental & clinical pharmacology 33 (3) (2018)
Sylvain Couderc, Maryse Lapeyre Mestre, Robert Bourrel, Carle Paul, Jean-Louis Montastruc, Agnès Sommet
Infectious risk of biological drugs vs. traditional systemic treatments in moderate-to-severe psoriasis: a cohort analysis in the French insurance database. Fundamental & clinical pharmacology 32 (4) (2018)
Laurine Andre, Adeline Gallini, François Montastruc, Nicola Coley, Jean-Louis Montastruc, Bruno Vellas, Sandrine Andrieu, Virginie Gardette, null null
Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study. British journal of clinical pharmacology 85 (1) (2018)
Joseph Rwagitinywa, Maryse Lapeyre Mestre, Robert Bourrel, Jean-Louis Montastruc, Agnès Sommet
Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients. Fundamental & clinical pharmacology 32 (4) (2018)
François Montastruc, Justine Benevent, Anthony Touafchia, Leila Chebane, Mélanie Araujo, Emmanuelle Guitton-Bondon, Geneviève Durrieu, Christophe Arbus, Laurent Schmitt, Bernard Begaud, Jean-Louis Montastruc
Atropinic (anticholinergic) burden in antipsychotic-treated patients. Fundamental & clinical pharmacology 32 (1) (2017)
Jean-Louis Montastruc, Agnès Sommet, Jean-Louis Montastruc
Concomitant medications and obstructive sleep apnoea. British journal of clinical pharmacology 83 (10) (2017)